Skip to content

Comparison of the Efficacy of High-Flow Nasal Oxygen Therapy and Noninvasive Ventilation in patients with COPD Exacerbation

Comparison of the Efficacy of High-Flow Nasal Oxygen Therapy and Noninvasive Ventilation in patients with COPD Exacerbation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160516027929N7
Enrollment
68
Registered
2020-01-25
Start date
2019-07-23
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease (COPD). Chronic obstructive pulmonary disease with (acute) exacerbation

Interventions

Intervention 1: Intervention group: Intervention group: First, ABG will be measured and then HFNT will be performed and after 1 hour, ABG will be measured again. Then 30 minutes will be passed without

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The presence of chronic obstructive pulmonary disease (COPD) and acute respiratory failure pH < 7.35 Arterial pressure of carbon dioxide (PaCO2) equal to or greater than 45mmHg

Exclusion criteria

Exclusion criteria: - Mechanical ventilation in the past 60 days (using any non-invasive ventilation or high blood oxygen through the nasal cannula (HFNT) prior to enrollment in the study and after the onset of acute upper respiratory failure (AHRF) - Non-invasive ventilation for home care - Undesirable clinical condition (require a vasopressor for> 24 hours, acute coronary syndrome or life-threatening arrhythmias ( - Refusal of treatment - Disorder in more than two organs -Heart failure - The respiratory tract requires a tracheal intubation - Trauma or burn in the neck and face - Pregnancy - Refusal of consent - enter to other research protocols

Design outcomes

Primary

MeasureTime frame
PaCO2. Timepoint: before intervention- one hour after - half hour after- after intervention. Method of measurement: ABG.

Secondary

MeasureTime frame
SaO2. Timepoint: befor intervention-one hour after-half hour after- after intervention. Method of measurement: ABG.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtefeh Fakharian

Shahid Beheshti University of Medical Sciences

fakharian_2005@yahoo.com+98 21 2712 2000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026